281 related articles for article (PubMed ID: 16570858)
1. HIV-1 coreceptors and their inhibitors.
Ray N; Doms RW
Curr Top Microbiol Immunol; 2006; 303():97-120. PubMed ID: 16570858
[TBL] [Abstract][Full Text] [Related]
2. Coreceptor usage by HIV-1 and HIV-2 primary isolates: the relevance of CCR8 chemokine receptor as an alternative coreceptor.
Calado M; Matoso P; Santos-Costa Q; Espirito-Santo M; Machado J; Rosado L; Antunes F; Mansinho K; Lopes MM; Maltez F; Santos-Ferreira MO; Azevedo-Pereira JM
Virology; 2010 Dec; 408(2):174-82. PubMed ID: 20947116
[TBL] [Abstract][Full Text] [Related]
3. V3 recombinants indicate a central role for CCR5 as a coreceptor in tissue infection by human immunodeficiency virus type 1.
Chan SY; Speck RF; Power C; Gaffen SL; Chesebro B; Goldsmith MA
J Virol; 1999 Mar; 73(3):2350-8. PubMed ID: 9971818
[TBL] [Abstract][Full Text] [Related]
4. Evidence for common structural determinants of human immunodeficiency virus type 1 coreceptor activity provided through functional analysis of CCR5/CXCR4 chimeric coreceptors.
Pontow S; Ratner L
J Virol; 2001 Dec; 75(23):11503-14. PubMed ID: 11689632
[TBL] [Abstract][Full Text] [Related]
5. The CCR5 and CXCR4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype C.
Cilliers T; Nhlapo J; Coetzer M; Orlovic D; Ketas T; Olson WC; Moore JP; Trkola A; Morris L
J Virol; 2003 Apr; 77(7):4449-56. PubMed ID: 12634405
[TBL] [Abstract][Full Text] [Related]
6. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
[TBL] [Abstract][Full Text] [Related]
7. [Chemokine receptors and its importance in the replication cycle of human immunodeficiency virus: clinical and therapeutic implications].
Azevedo-Pereira JM; Santos-Costa Q
Acta Med Port; 2008; 21(5):497-504. PubMed ID: 19187693
[TBL] [Abstract][Full Text] [Related]
8. Primary human immunodeficiency virus type 2 (HIV-2) isolates, like HIV-1 isolates, frequently use CCR5 but show promiscuity in coreceptor usage.
Mörner A; Björndal A; Albert J; Kewalramani VN; Littman DR; Inoue R; Thorstensson R; Fenyö EM; Björling E
J Virol; 1999 Mar; 73(3):2343-9. PubMed ID: 9971817
[TBL] [Abstract][Full Text] [Related]
9. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease.
Berger EA; Murphy PM; Farber JM
Annu Rev Immunol; 1999; 17():657-700. PubMed ID: 10358771
[TBL] [Abstract][Full Text] [Related]
10. Chemokine receptors and human immunodeficiency virus infection.
Bieniasz PD; Cullen BR
Front Biosci; 1998 Jan; 3():d44-58. PubMed ID: 9407151
[TBL] [Abstract][Full Text] [Related]
11. Genotypic coreceptor analysis.
Sierra S; Kaiser R; Thielen A; Lengauer T
Eur J Med Res; 2007 Oct; 12(9):453-62. PubMed ID: 17933727
[TBL] [Abstract][Full Text] [Related]
12. [Viral entry as therapeutic target. Current situation of entry inhibitors].
Arenzana-Seisdedos F
Enferm Infecc Microbiol Clin; 2008 Oct; 26 Suppl 11():5-11. PubMed ID: 19133215
[TBL] [Abstract][Full Text] [Related]
13. Effect of HIV-1 subtype and tropism on treatment with chemokine coreceptor entry inhibitors; overview of viral entry inhibition.
Panos G; Watson DC
Crit Rev Microbiol; 2015; 41(4):473-87. PubMed ID: 24635642
[TBL] [Abstract][Full Text] [Related]
14. Cellular entry of HIV: Evaluation of therapeutic targets.
Pöhlmann S; Reeves JD
Curr Pharm Des; 2006; 12(16):1963-73. PubMed ID: 16787241
[TBL] [Abstract][Full Text] [Related]
15. Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: a comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac.
Chen Z; Gettie A; Ho DD; Marx PA
Virology; 1998 Jun; 246(1):113-24. PubMed ID: 9656999
[TBL] [Abstract][Full Text] [Related]
16. Will multiple coreceptors need to be targeted by inhibitors of human immunodeficiency virus type 1 entry?
Zhang YJ; Moore JP
J Virol; 1999 Apr; 73(4):3443-8. PubMed ID: 10074200
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 (co)receptors: implications for vaccine and therapy design.
Pollakis G; Paxton WA
Curr Pharm Des; 2010; 16(33):3701-15. PubMed ID: 21128884
[TBL] [Abstract][Full Text] [Related]
18. The synthetic peptide WKYMVm attenuates the function of the chemokine receptors CCR5 and CXCR4 through activation of formyl peptide receptor-like 1.
Li BQ; Wetzel MA; Mikovits JA; Henderson EE; Rogers TJ; Gong W; Le Y; Ruscetti FW; Wang JM
Blood; 2001 May; 97(10):2941-7. PubMed ID: 11342415
[TBL] [Abstract][Full Text] [Related]
19. Human immunodeficiency virus type 1 coreceptor switching: V1/V2 gain-of-fitness mutations compensate for V3 loss-of-fitness mutations.
Pastore C; Nedellec R; Ramos A; Pontow S; Ratner L; Mosier DE
J Virol; 2006 Jan; 80(2):750-8. PubMed ID: 16378977
[TBL] [Abstract][Full Text] [Related]
20. Roles of CD4 and coreceptors in binding, endocytosis, and proteolysis of gp120 envelope glycoproteins derived from human immunodeficiency virus type 1.
Kozak SL; Kuhmann SE; Platt EJ; Kabat D
J Biol Chem; 1999 Aug; 274(33):23499-507. PubMed ID: 10438529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
